ATC Group: R06A Antihistamines for systemic use

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R06A in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R06 Antihistamines for systemic use
3 R06A Antihistamines for systemic use

Group R06A contents

Code Title
R06AA Aminoalkyl ethers
R06AB Substituted alkylamines
R06AC Substituted ethylene diamines
R06AD Phenothiazine derivatives
R06AE Piperazine derivatives
R06AK Combinations of antihistamines
R06AX Other antihistamines for systemic use

Active ingredients in R06A

Active Ingredient Description
Acrivastine

Acrivastine, a structural analog of triprolidine hydrochloride, exhibits H1-antihistaminic activity in isolated tissues, animals, and humans, and has sedative effects in humans. The propionic acid derivative of acrivastine is a metabolite in several animal species (as well as in man) and also exhibits H1-antihistaminic activity.

Alimemazine

Alimemazine has a central sedative effect, comparable to that of chlorpromazine, but largely devoid of the latter’s antiadrenaline action. It has powerful antihistamine and anti-emetic actions. Alimemazine is used to treat neurosis, depression and anxiety of different origins. It prevents and relieves allergic conditions, which cause pruritus and urticaria by blocking histamine produced by the body during an allergic reaction. Alimemazine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.

Antazoline

Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.

Astemizole

Astemizole is an antihistamine drug, used to prevent sneezing, runny nose, itching and watering of the eyes, and other allergic symptoms.

Azelastine

Azelastine, a phthalazinone derivative is classified as a potent long-acting anti-allergic compound with selective H1 antagonist properties. An additional anti-inflammatory effect could be detected after topical ocular administration. Data from in vivo (pre-clinical) and in vitro studies show that azelastine inhibits the synthesis or release of the chemical mediators known to be involved in early and late stage allergic reactions e.g. leukotriene, histamine, PAF and serotonin.

Bamipine
Bilastine

Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral Η1 receptor antagonist affinity and no affinity for muscarinic receptors.

Brompheniramine
Carbinoxamine

Carbinoxamine is a histamine-H1 receptor blocking agent. It is an antihistamine with anticholinergic (drying) and sedative properties. Carbinoxamine appears to compete with histamine (type H1) for receptor sites on effector cells in the gastrointestinal tract, blood vessels and respiratory tract. Carbinoxamine is effective for the symptomatic treatment of seasonal and perennial allergic rhinitis; vasomotor rhinitis; allergic conjunctivitis due to inhalant allergens and foods; mild, uncomplicated allergic skin manifestations of urticaria and angioedema; dermatographism; as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

Cetirizine

Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors.

Chlorcyclizine
Chlorphenamine

Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity.

Chlorphenoxamine
Clemastine

Clemastine is an H1-receptor antagonist. It inhibits selectively the histamine receptors of the H1 type and reduces capillary permeability. It exerts a potent antihistaminic and antipruritic effect with a fast onset and long duration of action.

Cyclizine

Cyclizine is a histamine H1 receptor antagonist of the piperazine class which is characterised by a low incidence of drowsiness. It possesses anticholinergic and antiemetic properties. The exact mechanism by which cyclizine can prevent or suppress both nausea and vomiting from various causes is unknown.

Cyproheptadine

Cyproheptadine is a first generation antihistamine which also has anticholinergic and antiserotonergic activities that is used to treat allergic conditions including seasonal rhinitis, conjunctivitis, dermatitits and urticaria.

Desloratadine

Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-receptor antagonist activity. After oral administration, desloratadine selectively blocks peripheral histamine Η1-receptors because the substance is excluded from entry to the central nervous system.

Dexchlorpheniramine

Dexchlorpheniramine, the d-isomer of the racemic compound chlorpheniramine, is two times more active than chlorpheniramine. Dexchlorpheniramine does not prevent the release of histamine, but rather, competes with free histamine for binding at the H1-receptor sites, and competitively antagonizes the effects of histamine on H1-receptors in the GI tract, uterus, large blood vessels, and bronchial muscle. Blockade of H1-receptors also suppresses the formation of oedema, flare, and pruritus that result from histaminic activity. Since dexchlorpheniramine binds to central and peripheral H1-receptors, sedative effects are likely to occur. Dexchlorpheniramine has high antihistaminic activity, moderate anticholinergic effects and minimal sedative effects.

Dimenhydrinate

Dimenhydrinate is a theoclate salt of the ethanolamine derivative diphenhydramine. It exhibits reversible competitive antagonism with histamine for the capture of H1 receptors. It has anticholinergic (antimuscarinic) properties that explain the anti-emetic action of the drug in cases of labyrinthial irritation (nausea, vertigo), and the central suppression it causes.

Dimetindene

Dimetindene is an antihistaminic of the alkylamine group. Its action is the result of the capture of histamine Η1 subunits. It has mild anticholinergic and sedative action.

Diphenhydramine

Diphenhydramine is an ethanolamine-derivative antihistamine. It is an antihistamine with anticholinergic and marked sedative effects. It acts by inhibiting the effects on H1-receptors. Diphenhydramine is effective in reducing sleep onset (i.e., time to fall asleep) and increasing the depth and quality of sleep.

Diphenylpyraline
Doxylamine

Doxylamine, an ethanolamine, first-generation antihistamine crosses the blood-brain barrier and exerts an antiemetic action by selectively binding to H1 receptors in the brain. Doxylamine is an antihistamine commonly used as a sleep aid. This drug is also used to relieve symptoms of hay fever (allergic rhinitis), hives (rash or itching), and other allergic reactions. Doxylamine is also a potent anticholinergic.

Ebastine

Ebastine has been shown to produce a rapid and long-lasting inhibition of histamine-induced effect and to have a strong affinity towards H1-receptors.

Epinastine

Epinastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from the mast cell. Epinastine is selective for the histamine H1-receptor and has affinity for the histamine H2receptor. Epinastine also possesses affinity for the α1, α2, and 5-HT2–receptors.

Fexofenadine

Fexofenadine is a non-sedating H1 antihistamine. Fexofenadine is a pharmacologically active metabolite of terfenadine.

Isothipendyl
Ketotifen

Ketotifen is a histamine H1-receptor antagonist. In vivo animal studies and in vitro studies suggest the additional activities of mast cell stabilisation and inhibition of infiltration, activation and degranulation of eosinophils.

Levocetirizine

Levocetirizine, the ® enantiomer of cetirizine, is a potent and selective antagonist of peripheral H1-receptors. Pharmacodynamic studies in healthy volunteers demonstrate that, at half the dose, levocetirizine has comparable activity to cetirizine, both in the skin and in the nose.

Loratadine

Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.

Mebhydrolin
Meclozine

Meclizine is a first generation antihistamine that is used largely to treat vertigo and motion sickness.

Mepyramine

Mepyramine is a first generation antihistamine, targeting the H1 receptor. However, it rapidly permeates the brain and so often causes drowsiness as a side effect. Mepyramine is a histamine H1 receptor inverse agonist. It binds to a G protein-coupled form of the receptor and promotes a G protein-coupled inactive state of the H1 receptor that interferes with the Gq/11-mediated signaling. Mepyramine competes with histamine for binding at H1-receptor sites on the effector cell surface, resulting in suppression of histaminic edema, flare, and pruritus. The sedative properties of mepyramine occur at the subcortical level of the CNS. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.

Mequitazine

Mequitazine is a phenothiazine derivative with the actions and uses of antihistamines. Antihistamines diminish or abolish the main actions of histamine in the body by competitive, reversible blaockade of histamine receptor site on tissues; they do not inactivate histamine or prevent its synthesis or release. Antihistamines are used for palliative treatment of allergic reactions.

Methapyrilene
Mizolastine

Mizolastine possesses antihistamine and antiallergic properties due to a specific and selective antagonism of peripheral histamine H1 receptors.

Oxatomide
Oxomemazine
Pheniramine
Pimethixene
Promethazine

Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties.

Quifenadine
Rupatadine

Rupatadine is a second-generation antihistamine, long-acting histamine antagonist, with selective peripheral H1-receptor antagonist activity. Some of the metabolites (desloratadine and its hydroxylated metabolites) retain an antihistaminic activity and may partially contribute to the overall efficacy of the drug.

Thiethylperazine
Thonzylamine
Trimethobenzamide

Trimethobenzamide is used for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis. The mechanism of action of trimethobenzamide as determined in animals is obscure, but may involve the chemoreceptor trigger zone (CTZ), an area in the medulla oblongata through which emetic impulses are conveyed to the vomiting center; direct impulses to the vomiting center apparently are not similarly inhibited.

Tripelennamine

Related product monographs

Title Information Source Document Type  
AERIUS Film-coated tablets European Medicines Agency (EU) MPI, EU: SmPC
ALLEGRA ALLERGY Film coated tablet FDA, National Drug Code (US) MPI, US: SPL/Old
AVOMINE Tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
BELARMIN Syrup Υπουργείο Υγείας (CY) MPI, EU: SmPC
BENYLIN DRY COUGHS Syrup Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BENYLIN MUCUS COUGH MAX Oral solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BIODRAMINA Medicated chewing-gum Medicines Authority (MT) MPI, EU: SmPC
CETIZAL Film-coated tablet Health Products Regulatory Authority (ZA) MPI, Generic
CETRINE Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
CETRIZ Film coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
CLARITYN ALLERGY Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLARITYNE Syrup / Tablet Health Products Regulatory Authority (ZA) MPI, Generic
DASERGIN Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
DASSELTA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
EBASTEL Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
FENISTIL Oral drops, solution Υπουργείο Υγείας (CY) MPI, EU: SmPC
FEXOFAST Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
HAYLEVE Tablet MPI, EU: SmPC
ILAXTEN Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
KESTINE Coated tablet Web Search MPI, EU: SmPC
LORAPAED ALLERGY RELIEF Oral solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LORATADINE Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LORYTEC Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
MIZOLLEN Modified-release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MUNTEL Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
Neoclarityn 5 mg film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NYTOL ONE-A-NIGHT Tablet Diphenhydramine Health Products Regulatory Authority (IE) MPI, EU: SmPC
PHENERGAN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PHENERGAN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
PIRITON Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PRIMALAN Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
RAZTROL Tablet Health Products Regulatory Authority (ZA) MPI, Generic
REACTINE Tablet, Capsule, Syrup Health Products and Food Branch (CA) MPI, CA: SPM
RHINETON Tablet Health Products Regulatory Authority (ZA) MPI, Generic
RINIALER Oral solution Medicines Authority (MT) MPI, EU: SmPC
RINIALER Tablet Medicines Authority (MT) MPI, EU: SmPC
RINOZAL Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
RUPAFIN Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
SENSAHIST Film-coated tablet Marketing Authorisation Holder MPI, Generic
SOMINEX Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TAVEGIL Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TELFAST Film-coated tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
TEXAMER Film-coated tablet Health Products Regulatory Authority (ZA) MPI, Generic
TICEVIS Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
UNISOM SLEEPGELS Capsule Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
VALOID Solution for injection Health Products Regulatory Authority (IE) MPI, EU: SmPC
VALOID Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
XYZAL Oral solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ZADITEN Eye drops, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
ZADITEN Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
ZIREX Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ZIRTEK ALLERGY Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ZOBRAL Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ZYRTEC Film-coated tablet / Oral drops / Oral solution Health Sciences Authority (SG) MPI, Generic